Cannabis smoke triggers many of the same harmful changes in airway cells as tobacco smoke | Research

The takeaway

In lab-grown human airway cells, cannabis smoke caused DNA damage, impaired immune defenses, and triggered inflammatory responses strikingly similar to tobacco smoke.

Cannabis users who smoke, public health researchers, and policymakers developing cannabis regulations.

Similar to tobacco smoke

What the researchers found

Cannabis smoke induced gene expression profiles that overlapped significantly with tobacco smoke, including DNA replication stress, oxidative stress responses, impaired epithelial barrier function, suppressed antiviral pathways, and increased inflammatory mediator production.

Why it matters

As cannabis legalization expands, understanding the respiratory effects of smoked cannabis becomes a public health priority. This study provides some of the first controlled molecular evidence that cannabis smoke may not be as harmless to lungs as some users assume.

The numbers in context

Cannabis smoke impaired epithelial barrier function, suppressed antiviral responses, and increased inflammatory mediators. Gene expression changes showed significant correlation with published tobacco smoke exposure datasets from human bronchial brushings.

How the study worked

In vitro study exposing human airway epithelial cells (Calu-3 cell line) to cannabis smoke with tobacco smoke as a positive control. Functional and transcriptomic (gene expression) analyses were performed.

What this study cannot tell us

This was an in vitro study using a single cell line, not human lungs. The exposure conditions may not perfectly replicate real-world smoking patterns. Long-term and dose-dependent effects cannot be assessed in this model.

How to read the evidence

Rated preliminary because this is an in vitro study using a single cell line. While the molecular findings are striking, they need validation in human subjects.

When this study was published

Published in 2019, shortly after Canadian legalization. More research on cannabis smoke effects has likely followed.

The bigger picture

Tobacco smoke science took decades to build. Cannabis smoke research is in its infancy by comparison. This study suggests the molecular damage pathways may be more similar between the two than previously appreciated, though in vitro findings need confirmation in human studies.

Questions still open

Do these molecular changes translate to actual lung disease in cannabis smokers? How do vaporized cannabis or edibles compare? Does frequency of use create a meaningful dose-response relationship for airway damage?

Common questions

Is cannabis smoke as bad as tobacco smoke for your lungs?

This lab study found striking molecular similarities between the two, including DNA damage and impaired immune responses. However, this was tested in cell cultures, not in human lungs, so direct equivalence cannot be assumed.

Does this apply to vaping or edibles?

No. This study specifically tested combusted cannabis smoke. Different delivery methods would need separate investigation.

Did the study look at cancer risk?

The study found cannabis smoke induced oncogenic gene expression signatures, suggesting potential cancer-related pathways were activated, but it did not measure actual cancer outcomes.

Read the original research

Transcriptomic and barrier responses of human airway epithelial cells exposed to cannabis smoke.

Physiological reports, 7(20), e14249

View on PubMed ↗Publisher’s paper ↗

Citation

Aguiar, Jennifer A; Huff, Ryan D; Tse, Wayne; Stämpfli, Martin R; McConkey, Brendan J; Doxey, Andrew C; Hirota, Jeremy A. (2019). Transcriptomic and barrier responses of human airway epithelial cells exposed to cannabis smoke.. Physiological reports, 7(20), e14249. https://doi.org/10.14814/phy2.14249